Multifunctionality of PAI-1 in fibrogenesis:: Evidence from obstructive nephropathy in PAI-1-overexpressing mice

被引:117
作者
Matsuo, S
López-Guisa, JM
Cai, XH
Okamura, DM
Alpers, CE
Bumgarner, RE
Peters, MA
Zhang, GQ
Eddy, AA
机构
[1] Univ Washington, Dept Pediat, Seattle, WA 98105 USA
[2] Childrens Hosp & Reg Med Ctr, Seattle, WA 98105 USA
[3] Univ Washington, Dept Pathol, Seattle, WA 98105 USA
[4] Univ Washington, Dept Microbiol, Seattle, WA 98105 USA
关键词
interstitial fibrosis; plasminogen activator inhibitor-1; macrophage; urokinase; unilateral ureteral obstruction;
D O I
10.1111/j.1523-1755.2005.00327.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Plasminogen activator inhibitor-1 (PAI-1) has been implicated in the pathogenesis of chronic kidney disease based on its up-regulated expression and on the beneficial effects of PAI-1 inhibition or depletion in experimental models. PAI-1 is a multifunctional protein and the mechanisms that account for its profibrotic effects have not been fully elucidated. Methods. The present study was designed to investigate PAI-1-dependent fibrogenic pathways by comparing the unilateral ureteral obstruction model (UUO) (days 3, 7, and 14) in PAI-I-overexpressing mice (PAI-1 tg) to wild-type mice, both on a C57BL6 background. Results. Following UUO, total kidney PAI-1 mRNA and/or protein levels were significantly higher in the PAI-1 tg mice (N = 6 to 8/group) and fibrosis severity was significantly worse (days 3, 7, and 14), measured both as Sirius red-positive interstitial area (e.g., 10 +/- 3.2% vs. 4.5 +/- 1.0%) (day 14) and total kidney collagen (e.g., 11.1 +/- 1.7 vs. 6.2 +/- 1.3 mu g/mg) (day 14). By day 14, the expression of two normal tubular proteins, E-cadherin and Ksp-cadherin, were significantly lower in the PAI-1 tg mice (3.2 +/- 0.5% vs. 11.7 +/- 5.9% and 2.6 +/- 1.6) vs. 6.2 +/- 0.8%, respectively), implying more extensive tubular damage. At least four fibrogenic pathways were differentially expressed in the PAI-1 tg mice. First, interstitial macrophage recruitment was more intense (P < 0.05 days 3 and 14). Second, interstitial myofibroblast density was greater (P < 0.05 days 3 and 7) despite similar numbers of proliferating tubulointerstitial cells. Third, transforming growth factor-beta 1 (TGF-beta 1) and collagen I mRNA were significantly higher. Finally, urokinase activity was significantly lower (P < 0.05 days 7 and 14) despite similar mRNA levels. Gene microarray studies documented that that the deletion of this single profibrotic gene had far-reaching consequences on renal cellular responses to chronic injury. Conclusion. These data provide further evidence that PAI-1 is directly involved in interstitial fibrosis and tubular damage via two primary overlapping mechanisms: early effects on interstitial cell recruitment and late effects associated with decreased urokinase activity.
引用
收藏
页码:2221 / 2238
页数:18
相关论文
共 47 条
[21]   MECHANISM OF PAI-1 ANTI-PROLIFERATIVE ACTIVITY TOWARDS LUNG AND PROSTATE CANCER CELLS [J].
Rozy, Adriana ;
Kedzior, Marta ;
Chorostowska-Wynimko, Joanna ;
Jagus, Paulina ;
Skronski, Michal ;
Szpechcinski, Adam ;
Skrzypczak-jankun, Ewa ;
Jankun, Jerzy .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) :S716-S717
[22]   Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury [J].
Sapru, Anil ;
Curley, Martha A. Q. ;
Brady, Sandra ;
Matthay, Michael A. ;
Flori, Heidi .
INTENSIVE CARE MEDICINE, 2010, 36 (01) :157-163
[23]   Targeting the PAI-1 Mechanism with a Small Peptide Increases the Efficacy of Alteplase in a Rabbit Model of Chronic Empyema [J].
Florova, Galina ;
De Vera, Christian J. ;
Emerine, Rebekah L. ;
Girard, Rene A. ;
Azghani, Ali O. ;
Sarva, Krishna ;
Jacob, Jincy ;
Morris, Danna E. ;
Chamiso, Mignote ;
Idell, Steven ;
Komissarov, Andrey A. .
PHARMACEUTICS, 2023, 15 (05)
[24]   SPECIFICITY OF ANTIGEN ASSAYS OF PLASMINOGEN-ACTIVATOR INHIBITOR IN PLASMA - INNOTEST PAI-1 IMMUNOASSAY EVALUATED [J].
MEIJER, P ;
POLLET, DE ;
WAUTERS, J ;
KLUFT, C .
CLINICAL CHEMISTRY, 1994, 40 (01) :110-115
[25]   A 5-hydroxytryptamine receptor antagonist, sarpogrelate, reduces renal tubulointerstitial fibrosis by suppressing PAI-1 [J].
Hamasaki, Yoshifumi ;
Doi, Kent ;
Maeda-Mamiya, Rui ;
Ogasawara, Emi ;
Katagiri, Daisuke ;
Tanaka, Tamami ;
Yamamoto, Tokunori ;
Sugaya, Takeshi ;
Nangaku, Masaomi ;
Noiri, Eisei .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2013, 305 (12) :F1796-F1803
[26]   Increased PAI-1 in females compared with males is protective for abdominal aortic aneurysm formation in a rodent model [J].
DiMusto, Paul D. ;
Lu, Guanyi ;
Ghosh, Abhijit ;
Roelofs, Karen J. ;
Su, Gang ;
Zhao, Yunge ;
Lau, Christine L. ;
Sadiq, Omar ;
McEvoy, Brendan ;
Laser, Adriana ;
Diaz, Jose A. ;
Wakefield, Thomas W. ;
Henke, Peter K. ;
Eliason, Jonathan L. ;
Upchurch, Gilbert R., Jr. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2012, 302 (07) :H1378-H1386
[27]   PAI-1 promotes the accumulation of exudate macrophages and worsens pulmonary fibrosis following type II alveolar epithelial cell injury [J].
Osterholzer, John J. ;
Christensen, Paul J. ;
Lama, Vibha ;
Horowitz, Jeffrey C. ;
Hattori, Noboru ;
Subbotina, Natalya ;
Cunningham, Andrew ;
Lin, Yujing ;
Murdock, Benjamin J. ;
Morey, Roger E. ;
Olszewski, Michal A. ;
Lawrence, Daniel A. ;
Simon, Richard H. ;
Sisson, Thomas H. .
JOURNAL OF PATHOLOGY, 2012, 228 (02) :170-180
[28]   Feasibility of Measuring the Prognostic Factors uPA and PAI-1 in Core Needle Biopsy Breast Cancer Specimens [J].
Thomssen, Christoph ;
Harbeck, Nadia ;
Dittmer, Juergen ;
Abraha-Spaeth, Shanti R. ;
Papendick, Nancy ;
Paradiso, Angelo ;
Lisboa, Bjoern ;
Jaenicke, Fritz ;
Schmitt, Manfred ;
Vetter, Martina .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (14) :1028-1029
[29]   UPA/PAI-1: a tool for breast cancer treatment individualization. Biology, clinical implications and quantification assays [J].
Lamy, P. -J. ;
Romieu, G. ;
Jacot, W. .
BULLETIN DU CANCER, 2010, 97 (03) :341-348
[30]   Role of plasminogen activator inhibitor-1 (PAI-1) in regulating the pathogenesis of S. aureus arthritis via plasminogen pathway [J].
Sultana, Sahin ;
Dey, Rajen ;
Bishayi, Biswadev .
IMMUNOLOGY LETTERS, 2019, 209 :53-66